265 related articles for article (PubMed ID: 23668802)
1. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
[TBL] [Abstract][Full Text] [Related]
2. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
[TBL] [Abstract][Full Text] [Related]
3. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
6. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.
Brown M; Hughes KR; Moossavi S; Robins A; Mahida YR
Clin Exp Immunol; 2014 Oct; 178(1):28-39. PubMed ID: 24828022
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
[TBL] [Abstract][Full Text] [Related]
9. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
10. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
[TBL] [Abstract][Full Text] [Related]
11. Epithelial expression of interleukin-37b in inflammatory bowel disease.
Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease.
Steenholdt C; Andresen L; Pedersen G; Hansen A; Brynskov J
Scand J Gastroenterol; 2009; 44(2):195-204. PubMed ID: 18985539
[TBL] [Abstract][Full Text] [Related]
13. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair.
Playford RJ; Belo A; Poulsom R; Fitzgerald AJ; Harris K; Pawluczyk I; Ryon J; Darby T; Nilsen-Hamilton M; Ghosh S; Marchbank T
Gastroenterology; 2006 Sep; 131(3):809-17. PubMed ID: 16952550
[TBL] [Abstract][Full Text] [Related]
14. Expression of the genes dual oxidase 2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease.
Csillag C; Nielsen OH; Vainer B; Olsen J; Dieckgraefe BK; Hendel J; Vind I; Dupuy C; Nielsen FC; Borup R
Scand J Gastroenterol; 2007 Apr; 42(4):454-63. PubMed ID: 17454855
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.
Oikonomou KA; Kapsoritakis AN; Theodoridou C; Karangelis D; Germenis A; Stefanidis I; Potamianos SP
J Gastroenterol; 2012 May; 47(5):519-30. PubMed ID: 22200942
[TBL] [Abstract][Full Text] [Related]
16. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.
Nielsen BS; Borregaard N; Bundgaard JR; Timshel S; Sehested M; Kjeldsen L
Gut; 1996 Mar; 38(3):414-20. PubMed ID: 8675096
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.
Sponheim J; Pollheimer J; Olsen T; Balogh J; Hammarström C; Loos T; Kasprzycka M; Sørensen DR; Nilsen HR; Küchler AM; Vatn MH; Haraldsen G
Am J Pathol; 2010 Dec; 177(6):2804-15. PubMed ID: 21037074
[TBL] [Abstract][Full Text] [Related]
18. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
[TBL] [Abstract][Full Text] [Related]
19. Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
Sugitani Y; Nishida A; Inatomi O; Ohno M; Imai T; Kawahara M; Kitamura K; Andoh A
J Gastroenterol; 2020 Apr; 55(4):408-417. PubMed ID: 31916038
[TBL] [Abstract][Full Text] [Related]
20. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.
Wehkamp J; Fellermann K; Herrlinger KR; Baxmann S; Schmidt K; Schwind B; Duchrow M; Wohlschläger C; Feller AC; Stange EF
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):745-52. PubMed ID: 12169983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
